Piotr Wnuk, Author at - Page 13 of 14

Summit Therapeutics has axed development of its Duchenne muscular dystrophy drug ezutromid after a spectacular failure in phase

Summit shares plunge nearly 80% after DMD drug fails

https://pharmaphorum.com/news/summit-shares-plunge-dmd-drug-fail/

Deep Dive/ Digital/ Sales and Marketing/ Views & Analysis/ Views & Analysis

How to achieve digital success in pharma’s communications

Piotr Wnuk Anthill, Anthill Academy, digital, digital content strategy, digital strategy 0 Comment

Demystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for

How to achieve digital success in pharma’s communications

https://pharmaphorum.com/views-analysis-digital/achieve-digital-success-pharma/

News/ News/ News/ Oncology/ Startups

AbbVie leads $53m investment macrophage cancer tech

Piotr Wnuk AbbVie, cancer, Carisma Therapeutics, Oncology 0 Comment

A duo of University of Pennsylvania scientists have stepped out with multi-million dollar backing from investors including AbbVie,

AbbVie leads $53m investment macrophage cancer tech

https://pharmaphorum.com/news/53m-investment-carisma-therapeutics/

News/ News/ News/ Patients/ R&D/ Top stories

Sunovion’s Parkinson’s disease drug is a step closer to approval

Piotr Wnuk neurology, Parkinson's disease, Sunovion 0 Comment

The U.S. pharma Sunovion has said its under-the-tongue film for Parkinson’s has hit target in a late stage

Sunovion’s Parkinson’s disease drug is a step closer to approval

https://pharmaphorum.com/news/sunovions-parkinsons-disease-drug-step-closer-approval/

Patients/ Views & Analysis/ Views and analysis

The time has come to optimise patient engagement

Piotr Wnuk 0 Comment

A paradigm shift is occurring as patient engagement moves from an abstract concept to a pragmatic reality, and

The time has come to optimise patient engagement

https://pharmaphorum.com/patients/time-optimise-patient-engagement/

Diabetes/ News/ News/ News/ Novo Nordisk/ Patients/ R&D/ Top pharmaceutical companies/ Top stories

Real-world diabetes study CONFIRMs positive comparative efficacy for Novo’s Tresiba

Piotr Wnuk Diabetes, Novo Nordisk, Sanofi, Toujeo, Tresiba 0 Comment

Novo Nordisk presented the latest results for its diabetes injectable Tresiba last weekend. These demonstrated significantly better control

Real-world diabetes study CONFIRMs positive comparative efficacy for Novo’s Tresiba

https://pharmaphorum.com/news/tresiba-improved-sugar-control-decreased-hypos/

Diabetes/ Diabetes/ News/ News/ News/ Novo Nordisk/ Patients/ R&D/ Top pharmaceutical companies/ Top stories

Novo’s diabetes pill beats injections in head-to-head trials

Piotr Wnuk Diabetes, diabetes care, GLP-1, Insuline, Januvia, Novo Nordisk, semaglutide, Sitagliptin, Type 2 diabetes, Victoza 0 Comment

Novo Nordisk is making the case for its diabetes pill, which it hopes will allow it to fight

Novo’s diabetes pill beats injections in head-to-head trials

https://pharmaphorum.com/news/novo-nordisks-success-with-oral-diabetes-drug/

Views and analysis

New NICE processes – same old problem?

Piotr Wnuk NICE, Processes of Technology Appraisal 0 Comment

Following two recent controversial public consultations, NICE recently updated its Guide to the Processes of Technology Appraisal. The

New NICE processes – same old problem?

https://pharmaphorum.com/views-and-analysis/new-nice-processes-same-old-problem/

News/ News/ Patients

Opioid misuse lead to at least 456 deaths in UK hospital

Piotr Wnuk Gosport, Gosport War Memorial Hospital, opiod abuse, Opiod crisis, opiod epidemic 0 Comment

Care standards and ethics in the NHS are once again under scrutiny after a report found that overprescription

Opioid misuse lead to at least 456 deaths in UK hospital

https://pharmaphorum.com/news/opioid-kills-gosport-hospital-patients-uk/

Trending

About Piotr Wnuk

Posts by Piotr Wnuk:

Summit shares plunge nearly 80% after DMD drug fails

How to achieve digital success in pharma’s communications

AbbVie leads $53m investment macrophage cancer tech

Sunovion’s Parkinson’s disease drug is a step closer to approval

The time has come to optimise patient engagement

Real-world diabetes study CONFIRMs positive comparative efficacy for Novo’s Tresiba

Novo’s diabetes pill beats injections in head-to-head trials

New NICE processes – same old problem?

Opioid misuse lead to at least 456 deaths in UK hospital

Trending

About Piotr Wnuk

Posts by Piotr Wnuk:

Login